Form 8-K - Current report:
SEC Accession No. 0001104659-06-063198
Filing Date
2006-09-26
Accepted
2006-09-26 17:23:04
Documents
4
Period of Report
2006-09-22
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-20181_18k.htm 8-K 29201
2 EX-3 a06-20181_1ex3d1.htm EX-3.1 397466
3 EX-99 a06-20181_1ex99d1.htm EX-99.1 17100
4 GRAPHIC g201811mmi001.jpg GRAPHIC 2778
  Complete submission text file 0001104659-06-063198.txt   449510
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 061109479
SIC: 2835 In Vitro & In Vivo Diagnostic Substances